Comparison of platinum agents cisplatin and carboplatin in routine treatment of advanced NSCLC – results from prospective German TLK cohort study. 15. Januar 2018 von Verschuer, U., Schnell, R., Zahn, M.-O., Eggert, J., Binninger, A., Spring, L., Jänicke, M., Marschner, N., 2017. Ann Oncol 28 (suppl 5)(1370P), 490. Abstract Clinical Research platform Into molecular testing, treatment and outcome of non-Small cell lung carcinoma Patients (CRISP): a prospective German Registry in stage IV NSCLC AIO-TRK-0315) F. Griesinger, W. Eberhardt, N. Marschner, M. Jänicke, A. Fleitz, L. Spring, J. Sahlmann, A. Karatas, A. Hipper, W. Weichert, M. Sebastian, M. Thomas, 2017. Weiterlesen Prognostic factors for overall survival of patients with advanced renal cell carcinoma – data from the German prospective RCC-Registry. Goebell, P. J., Müller, L., Staehler, M., Müller, M., Frank, M., Kruggel, L., Jänicke, M., Marschner, N., for the RCC Registry group, 2017. Ann Oncol… Weiterlesen